Microbot Medical (FRA:CY9D) EPS (Basic): €-0.22 (TTM As of Mar. 2026)

What is Microbot Medical EPS (Basic)?

Microbot Medical FRA:CY9D +0.64% 29 EPS (Basic) is €-0.22 as of Mar. 2026. GuruFocus rates FRA:CY9D with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Microbot Medical's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €-0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.22.

Microbot Medical's EPS (Diluted) for the three months ended in Mar. 2026 was €-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.22.

Microbot Medical's EPS without NRI for the three months ended in Mar. 2026 was €-0.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.22.

During the past 3 years, the average EPS without NRI Growth Rate was 46.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 25.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 35.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Microbot Medical's highest 3-Year average EPS without NRI Growth Rate was 86.80% per year. The lowest was -14.90% per year. And the median was 15.10% per year.

Microbot Medical (FRA:CY9D) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Microbot Medical EPS (Basic) Related Terms

Microbot Medical EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Microbot Medical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbot Medical EPS (Basic) Chart

Microbot Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

-1.41

-1.71

-0.96

-0.70

-0.25

Microbot Medical Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															-0.07	-0.09	-0.06	-0.03	-0.04

29GF Score

Microbot Medical Inc FRA:CY9D

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Microbot Medical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Microbot Medical's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-11.223	-	0)	/	45.790
	=	-0.25

Microbot Medical's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3.175	-	0)	/	67.158
	=	-0.05

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.22

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of €-0.22 mean?

Microbot Medical (FRA:CY9D) has a EPS (Basic) of €-0.22 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Microbot Medical and its competitors.

Is Microbot Medical's EPS (Basic) too high?

Microbot Medical's current EPS (Basic) is €-0.22. Overall, Microbot Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.

How does Microbot Medical's EPS (Basic) compare to KRMD and STXS?

Microbot Medical's EPS (Basic) of €-0.22 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Devices & Instruments company?

A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Microbot Medical and its competitors. Microbot Medical's current EPS (Basic) is €-0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Microbot Medical stock overvalued right now?

Microbot Medical (FRA:CY9D) has a current EPS (Basic) of €-0.22. The current EPS (Basic) is €-0.22. Microbot Medical's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Microbot Medical (FRA:CY9D), the current EPS (Basic) is €-0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microbot Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies KRMD STXS EMBC PDEX SMTI UTMD DXR POCI NEPH MLSS ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges MBOT:USA

Address 175 Derby Street, Building 27, Hingham, MA, USA, 02043

Website https://www.microbotmedical.com

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

29GF Score

Get the complete analysis for FRA:CY9D

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.57

Price

View FRA:CY9D Analysis

See EPS (Basic) data for all stocks →